Dr. Gearóid Tuohy

Intermediate Age-Related Macular Degeneration (iAMD) has demonstrated useful comparisons between visual function tests within a research setting

The researchers at the Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, have reported that the five visual function parameters commonly… Read More »Intermediate Age-Related Macular Degeneration (iAMD) has demonstrated useful comparisons between visual function tests within a research setting

Editas Medicine, Inc. (NASDAQ; EDIT) has announced positive clinical data on their CRISPR gene therapy product on LCA10

Editas Medicine, Inc. (NASDAQ: EDIT) has announced positive initial clinical data from an ongoing, open label Phase I/II “BRILLIANCE” study EDIT-101, a CRISPR-based experimental treatment… Read More »Editas Medicine, Inc. (NASDAQ; EDIT) has announced positive clinical data on their CRISPR gene therapy product on LCA10

FDA approval announces the first biosimilar in the USA for ranibizumab (Lucentis) intravitreal injection in neovascular AMD, RVO and myopic CNV

The US FDA (Food and Drug Administration) has approved authorisation for “Byooviz” (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) “for the treatment of… Read More »FDA approval announces the first biosimilar in the USA for ranibizumab (Lucentis) intravitreal injection in neovascular AMD, RVO and myopic CNV